ELEKTA’S IMAGE GUIDED TREATMENT SOLUTIONS RECEIVE REGULATORY APPROVAL IN CANADA

PRESS RELEASE Stockholm, October 12, 2005 Approval for the next generation of Elekta’s Synergy® Platform and X-ray Volume Imaging by Canada's government health agency, Health Canada, gives Canadian clinicians effective new workflow tools for IGRT and 4D Adaptive™ radiation therapy.

Image Guided Radiation Therapy (IGRT) is the next generation in radiation oncology treatment accuracy, giving clinicians the ability to image a patient at the point of treatment, make corrections to better target a tumor, and avoid surrounding healthy tissue. Elekta was the first company to develop IGRT and the first to bring it to market, and remains the world leader in this next generation of treatment accuracy. With more than 4,000 clinical images from 20 installations, and more than 50 systems scheduled to be installed, Elekta’s system has proven its clinical effectiveness and is tantalizing clinicians with its future potential. ******

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links